Abstract
BACKGROUND Peripheral inflammation is often associated with depressive disorders, and immunological biomarkers of depression remain a focus of investigation.
METHODS We performed RNA-seq analysis of human peripheral blood mononuclear cell (PBMC) RNA transcripts from a case-control study including subjects with self-reported depression in the pre-symptomatic state of major depressive disorder (MDD), and analysed differential expression of genes (DEGs) and intron retention (IR) using rMats.
RESULTS Among the DEGs with a statistically significant value, both 651 up-regulated and 820 down-regulated genes were enriched in GO (gene ontology) terms of innate and adaptive immunity. The former was particularly enriched in bacterial infection and phagocytosis, while the latter was enriched in genes related to antigen presentation and T cell proliferation and maturation. Genes with the 158 increased and 211 decreased IRs (termed IncIR and DecIR genes, respectively) in the depressed subjects were analysed. Their GO terms were very similar to those of the up- and down-regulated genes, with an emphasis on ciliary assembly and function in the DecIR. The results also showed that a Japanese herbal medicine partially reversed the depression in these subjects after recovering the DecIR and IncIR genes. By imposing the recovered genes on the network of depressed subjects, several new pathways for recovery from depression were successfully discovered.
CONCLUSION Depression was associated with activation of the innate immune response and relative inactivation of T cell signalling. DEGs reflect physiological demands that are controlled at the transcriptional level, whereas IRs are a more direct mechanism for monitoring protein homeostasis. Accordingly, IR is a stress response and IR genes are sensors of the physiological state in the cytoplasm. In particular, where ciliary genes were detected by IR analysis, it is expected that there is a defect in ciliary function or immunological synapse in depression. We demonstrate the potential of IR biomarkers in the immunological stratification of depressed patients and their utility in the discovery of novel pathways involved in recovery from depression.
Introduction
In 2017, it was estimated that more than 320 million people worldwide were affected by clinical depression (1). It is likely that this number - along with the number of people affected by other mental disorders - is increasing as the stresses of everyday life continue to rise, particularly since the outbreak of COVID-19. In fact, depression has become the leading cause of disability worldwide. Major depressive disorder (MDD) is often accompanied by anxiety disorder, which is also the leading cause of death by suicide (1). Currently, there is no reliable laboratory test or effective treatment strategy to diagnose or cure MDD. Another important issue in depression is the low remission rate, with only about half of patients achieving complete remission and the remission rate decreasing with each subsequent treatment. Therefore, to better understand the pathogenesis of depression and its aetiology, there is an urgent need to identify biomarkers for monitoring treatment outcome and genes that can be targeted for drug therapy (2, 3, 4, 5, 6).
There is increasing evidence that depression and inflammation are often associated (7, 8, 9, 10, 11, 12, 13, 14). Several case-control studies of major depressive disorder (MDD) have reported elevated peripheral blood levels of inflammatory cytokines such as CRP, interleukin 6 and tumour necrosis factor in MDD (15, 16, 17). In these cases, where inflammation occurs first and depressive symptoms appear later, the view that inflammation is the cause of depression is gaining ground. Furthermore, the prevalence of comorbid depression is increased in many non-psychotic inflammatory diseases, such as rheumatoid arthritis (18), suggesting a possible causal role of inflammation in depression. Ed. Bullmore (in his excellent book “THE INFLAMED MIND”(19)) has proposed that stress causes inflammation and that inflammation causes depression. Much of the current data seems to be consistent with his proposal (20).
Alternative pre-mRNA splicing is a mechanism by which multiple protein isoforms can be produced from a single gene transcript. One type of alternative splicing is termed ‘intron retention’ (IR), which was previously thought to simply reflect one or more errors during pre-mRNA splicing. More recently, however, IR has been considered to be a biologically meaningful phenomenon rather than an alternative splicing error, as an increase or decrease in the amount of introns has been associated with certain biological phenomena, such as cell differentiation (21, 22, 23, 24), ageing (25) and oncogenesis (26). Using mouse models of ageing such as Klotho mice (27) and SAMP8 mice (28), we have previously shown that IR occurs as a stress response in the pre-symptomatic state and that when the state is restored by administration of the Japanese herbal medicine, the incidence of IR is restored to that of the healthy state (27, 28). In addition, we have proposed that genes affected by IR (termed IR genes) play a sensor role in detecting perturbations in cellular homeostasis (29).
We hypothesised that by analysing the IR genes, it would be possible to identify the stresses experienced by patients and the gene dysfunctions that are hidden as causes of their depression. In other words, we wanted to explore the possibility of using IR as a means of investigating aetiology.
Materials and Methods
Ethics declarations, ethics approval and consent to participate
This research has been reviewed and approved by the Kitasato Institute Hospital, Research Ethics Committee and assigned research number 21037. Please note that the study on which this research is based is an interventional study and has the following approval numbers No. 21039, UMIN Study ID: UMIN000045707. Please also note that the Kitasato Institute Hospital, Research Ethics Committee deliberates in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan. Other documents were prepared in accordance with the guidelines and the study was initiated. All subjects who participated in the study gave written consent to the research procedures, including genetic analysis. The research procedures were conducted in accordance with the research protocol.
Subjects
We recruited subjects with depressive symptoms who had consented to participate in the “Study of Hangekobokuto (30) and the Intestinal Environment” conducted by the Kitasato University Oriental Medicine Research Center, and who scored between 6 and 20 on the Brief Depressive Symptom Scale (QIDS-J). After the benefits and risks of the study were explained to the subjects, written informed consent was obtained, and the following exclusion criteria were applied to those who consented. 1) Subjects already receiving treatment for depression, 2) Subjects who had taken herbal medicinal preparations within the previous 4 weeks, 3) Subjects who had taken antibiotics within the previous 4 weeks, 4) Subjects who were clearly in need of Western medical treatment, 5) Subjects who had been diagnosed with ulcerative colitis or Crohn’s disease, 6) subjects with clinically significant hepatic or renal impairment, 7) subjects who have participated in other clinical studies within the past 12 weeks, and 8) subjects who are deemed by the investigator to be unsuitable for the study.
Subjects took a daily dose of a Japanese herbal medicine, Hangekobokuto (HKT), at home. The BDI™-II Beck Depression Questionnaire (BDI-II) was administered at the time of the screening test and at hospital visits 2 months after taking HKT, and blood was collected using BD Vacutainer CPTTM Blood Collection Tubes (Nippon Becton Dickinson, Japan). Subjects were classified according to their BDI-II score, with 6 control subjects (CON) scoring less than 16 and 8 subjects with depression symptoms (before medical treatment (BMT) or after medical treatment (AMT)) scoring 17 or higher.
Japanese herbal medicine
Japanese herbal medicines originated in ancient China and are widely used in Japan for a variety of conditions (31, 32). HKT (30) is one of the formulations and is taken for symptoms of mental anxiety, stagnant gas in the stomach and usually poor digestive function. In this study, HKT was used as a decoction in the following proportions, based on the formula of the Kitasato University Oriental Medicine Research Centre: Hange (Pinelliae Tuber) 6.0 g; Bukuryo (Hoelen) 5.0 g; Koboku (Magnoliae Cortex) 3.0 g, Shisoyo (Perillae Herba) 2.0 g; Syokyo (Zingiberis Rhizoma) 0.5 g.
PBMCs preparation, RNA extraction, RNA library preparation and RNA-sequencing
Blood samples collected in BD Vacutainer CPTTM Blood Collection Tubes are centrifuged within 2 hours to separate the PBMC layer. After centrifugation, PBMC samples can be stored and transported at −80 °C. RNA extraction was performed on individual PBMC samples. Library construction and paired-end sequencing (150 base pairs × 2) using the NovaSeq 6000 platform (Illumina) were outsourced to Azenta Life Sciences, Tokyo, Japan. RNA sequencing yielded 109 ∼ 148 million (× 2, paired-ends) raw reads per sample. These were then purified using conventional procedures (33, 34, 35, 36).
Differential expressed genes (DEG) analysis
Using the edgeR package in R, significantly differentially expressed genes were detected by performing likelihood ratio tests. The results showed that 922 downregulated and 641 upregulated genes were significantly differentially expressed between the 6 CONs and 8 BMTs with P < 0.05 and fold-change > 1.2. DEGs were used for GO and KEGG pathway enrichment analysis using the DAVID website. Similarly, the same test was calculated under the same conditions between BMT and AMT to investigate the effect of HKT administration.
Detection of intron retentions
IR-containing genes were analysed to determine their possible role in stress sensing as proposed in the previous study (27, 28, 29). rMATS v.4.1. was used to assess the differential IR landscape embedded in the RNA-seq data. The optional parameters for the rMATS program are as follows: [--cstat 0.05 -t paired --readLength 150 --variable-read-length]. A cut-off of P < 0.05 in the likelihood ratio test and an absolute difference of the IR ratio > 0.05, used as the statistical significance test in the rMATS program, was used to call differential IR events. Similarly, the same test was calculated under the same conditions between BMT and AMT to study the effect of HKT administration.
Interactome analysis
A protein-protein interaction network was generated using Cytoscape ver. 3.9.1 with StringApp version 1.7.1. The network type “full STRING network” was selected for drawing and a confidence (score) cut-off value of 0.7 was used (Other parameters were used as default values.). Fig. 5 was calculated with a confidence (score) cut-off value of 0.7 using proteins encoded by IR genes and DEGs, and we analysed protein-protein interactions with each functional gene group, cilia-related genes (proteins), psychiatric disorders-relevant (PD) genes (proteins), adaptive and innate immunity related genes (proteins).
Results
RNA-seq and analysis of DEG
The study included a group of subjects with depression ranging from 17 to 27 on the BDI-II score, designated as BMT group (8 individuals), which is neither severe nor mild. Relatively mild subjects with scores ranging from 7 to 16 were used as controls, designated as CON group (6 individuals), and healthy subjects were not used as controls (Figure 1A(i)(ii)). As we are all on the spectrum, we wanted to gain molecular insight into the transition from mild to moderate depression. All subjects were also screened to ensure that they had not taken any medication or been hospitalised during the three-month period before examination (see details in the method section). These are the characteristics of subjects in this study. PBMC and RNA were isolated from each sample and used for RNA-seq. DEG analysis resulted in the identification of 651 upregulated and 820 downregulated genes for the BMT group compared to the CON group (Figure 1BC, Supplementary Table 1). GO enrichment analysis was performed for upregulated genes (Figure 1D, Supplementary Figure 1), showing enrichment for innate immunity-related terms such as infection, phagocytosis and inflammation as well as adaptive immunity, and for downregulated genes (Figure 1E, Supplementary Figure 2), showing enrichment for adaptive immunity-related terms such as antigen presentation, T cell activation as well as synapse-related terms. Figure 1B shows the genes involved in positive regulation of T cell activation (5 genes in Figure 1E) from the downregulated genes and the genes involved in innate immune responses (21 genes in Figure 1D) from the upregulated genes, which include a large number of immunoglobulin heavy chains (37, 38), suggesting an inflammatory phenotype of the subjects (37).
Identification of IncIR and DecIR genes in the depressed subjects
Since IR is a stress response and genes susceptible to IR are a physiological sensor ((27, 28); see later), we characterised genes for increased intron (IncIR) and those for decreased intron (DecIR) in depressed subjects, considering that such an analysis would give an indication of the type of stress to which the subjects were exposed. The 158 IncIR and 198 DecIR genes were isolated (Figure 2AB, Supplementary Table 2) and their characteristics were first studied from the literature. As expected, many sensor or regulatory genes were isolated from the protein-coding IR genes, some of which are shown in Table 1 (45 genes). This is only half of the genes identified as sensors, regulators and modulators among the IR genes in this analysis, in which genes controlling inflammation, innate immunity and adaptive immunity were found. Their GO enrichments were then analysed, as shown in Figure 2CD. In IncIR, TNF signalling pathway and several terms related to innate immune response were enriched, and in DecIR genes, T cell signalling and other adaptive immune response as well as inflammation and innate immune processes were enriched. In short, both innate and adaptive immunity were highlighted in the IR analysis, as in the case of the DEG analysis, suggesting that IR genes are mirrored by DEG genes. The important difference between IR genes and DEG genes is that immunoglobulin was included in the DEG list (in fact, almost half of the upregulated genes in our RNA-seq analysis are immunoglobulin genes, see Supplementary Figure 1), but not in the IR genes. The reason why immunoglobulin genes were not listed in the IR genes is discussed later. Most interestingly, the highest enrichment score of genes in DecIR was for cilium assembly, suggesting that cilium is involved in sensing depressive stress in these subjects (see Discussion).
IR genes statistically significantly interact with those for innate immune response
To characterise the IR genes in more detail, we first determined the possible overlap of IR genes with immune-related genes, cilia genes and psychiatric disease-related genes (PD genes) using a Venn diagram (Figure 3AB). Among the 317 IR genes (Supplementary Table 2), 32 cilia genes (Figure 3C) and 34 immune-related genes (Figure 3D) were included. Since many IR genes in Table 1 were involved in innate immunity, including viral and bacterial infection, we next examined whether IR genes could specifically interact with genes involved in the innate immune response (Figure 3E). Compared to the interaction of randomly chosen genes, IR genes interact with genes involved in innate immunity in a statistically significant manner. Figure 3F shows the ranking of the IR gene interactions. Among the IR genes, the STAT1 gene, signal transducer and activation of transcription gene 1 ((39); Table 1), has the highest number of interactions with innate immunity genes. It is interesting to note that this gene is an important member of the JAK-STAT pathway (39), which is involved in both innate and adaptive immunity including inflammation (see Discussion).
We also looked at the interaction of IR genes with genes involved in leukocyte activation (adaptive immunity) or immune response. Their ranking of IR gene interaction was informative (Figure 3JK), as STAT1 ranked highest in both cases.
IR-DEG interactome
Using all the protein-coding genes of DEG (285 up-regulated + 433 down-regulated) and IR (129 IncIR + 172 DecIR + 8 Mixed), we can create a large interactome using the PPI network software (Figure 4A). A large interactome was formed, with many hub genes connecting to other genes (Supplementary Table 3). The largest hub is the SRC gene (40), one of the DEGs, connected to 43 genes (Figure 4B). Among the IR genes, the largest hub was DLG4 (41), which is involved in synaptic function. The second was STAT1, a member of the JAK-STAT pathway (39). The third and fifth were integrin genes (42, 43), and the fourth was HLA-A (44), which is involved in antigen presentation. The sixth was MYH10 (45), myosin heavy chain, which has 11 links, one of which was linked to myosin light chain kinase (MYLK) (46, 47) and was restored by the administration of Japanese herbal medicine (see later).
Recovery of IR genes by administration of HKT
After 2 months of HKT administration, PMBC were isolated from the subjects and RNA-seq was performed (Figure 1A). We characterised two types of IR gene recovery, reverse V-shaped recovery (Figure 5A) and V-shaped recovery (Figure 5B), consisting of 30 and 34 protein-coding genes, respectively (Supplementary Table 4). Since only 17 genes (7 V-shaped genes and 10 reverse V-shaped genes) were recovered in DEG (data not shown), the fact that four times as many genes were recovered in IR suggests that IR is superior to DEG as a marker for evaluating the efficacy of a drug in the present case.
Characterisation of the IR genes restored by HKT (Figure 5C) showed that inflammation-related genes were the major restored IR genes (24 genes; 37.5%), with 7 mitochondria-related and 7 cilia-related genes each accounting for 10.9%. The anti-inflammatory effect shown here is consistent with the reported efficacy of many Japanese herbal medicines (31), including HKT (30). Interestingly, while HKT has been reported to have anti-inflammatory effects by reducing inducible nitric oxide synthase (iNOS), the IR of NOSIP (48), which has been reported as a modulator of NO, was consistently restored in the present study. The appearance of haemopoietic genes (3 genes) may also indicate that inflammation and haemopoiesis are linked in a compensatory way, as inflammation consumes a large number of macrophages. Oxidative stress is common in depressed patients (49) and can lead to increased DNA damage together with mitochondrial dysfunction (49). The restoration of these genes may be the hallmark of this herbal medicine.
Pathways recovered by herbal medicine can be characterized from the DEG-IR interactome
The recovered 64 IR genes shown in Figure 5 and 17 DEGs were superimposed on the DEG-IR interactome (shown in Figure 4) to determine whether these recovered genes can network with each other. Ten new pathways were found (Figure 6). Some of these pathways are known to have protein-protein interactions, but to our knowledge this is the first time that these pathways have been shown to be involved in restoring a physiological state. As the DEG-IR interactome was generated without the use of herbal medicines, different new pathways would be found if different medicines were used in the same patient. This means that this method can be used to discover new pathways involved in the mechanism of action of drugs.
Discussion
The upregulated genes in this study were significantly enriched in GO terms associated with innate and adaptive immunity. Many of these genes (approximately 50%) were related to immunoglobulin heavy chains (Figure 1B, Supplementary Table 1). In contrast, downregulated genes were enriched in GO terms associated with antigen presentation, T cell function and adaptive immunity. This trend in depressed patients has been reported previously (3, 4).
An important aspect of our study is that we have shown that IR can be used as an alternative method to detect specific changes in depression, in addition to traditional DEG methods. Roughly speaking, GOs detected in IncIR genes correspond to GOs of upregulated DEGs, whereas GOs detected in DecIR genes correspond to GOs of downregulated DEGs. This correspondence can be better understood in the light of our recently proposed intron fine-tuning model (29). That is, an increase in introns leads to a decrease in the amount of mature cytoplasmic mRNA (and thus a decrease in cytoplasmic protein), whereas a decrease in introns leads to an increase in mature cytoplasmic mRNA (and thus an increase in cytoplasmic protein). In other words, IR is thought to play a role in regulating the correct amount of protein in the cytoplasm. This is the molecular mechanism by which intracellular homeostasis is regulated.
As can be easily imagined from the model described above, genes that cause IR have a sensor role. Indeed, many of the IR genes analysed in this study have the word ‘sensor’ or ‘regulate’ in their title of the literature to describe their role (Table 1). Analysis of IR genes may reveal new, as yet unidentified, regulatory roles of these genes in the stress of depression.
In many cases, IR genes do not correspond to DEGs. Of the 30 DEGs shown in Figure 1B, only one gene, HLA-DRB1 (50), is actually subject to IR. DEGs are often quantitative, whereas IR genes are more qualitative. By analogy, the DEG is the soldier, the manual worker, whereas the IR genes is the commander in chief. A typical example of the qualitative difference between DEGs and IR genes is secreted proteins, where secreted proteins are sometimes detected as DEGs (indeed, half of the upregulated genes are immunoglobulins; Supplementary Figure 1), but not as IR genes. This is because these proteins are secreted out of the cell via the Golgi apparatus and are therefore not captured by the homeostasis detection mechanism in the cytoplasm.
There are 20-30,000 genes in the genome, some of which may have a predetermined role as commanders in causing IR. Indeed, in budding yeast, introns have been shown to play a mediator role in monitoring the physiological state of the cell (51, 52). Thus, the function of IRs as sensors described here is likely to be an evolutionarily conserved universal function. It remains to be seen by what mechanism this particular intron reflects physiological states and is involved in cellular homeostasis (29), which is a major challenge for the future.
Many researchers have analysed DEGs between case-controls to look for markers of depression. What has been found is that even when the top 10 genes with the highest expression variability are examined, the data differ from experiment to experiment and do not match (53). As shown in the current study, IR variation is likely to be more sensitive as a marker of depression. Consider this in practice: a 10% fluctuation in immunoglobulin levels in DEG would not represent the physiological state of many individuals, but a 10% reduction in the intron of the inflammation sensor STAT1 (39) would have a significant impact on immune homeostasis because it would increase the amount of STAT1 protein in the cytosol by 10%. The accumulation of various studies to date suggests that the cause of depression is polygenic (54), but it is more plausible that the reason why genes for better markers have not been found in the DEGs is due to the nature of the DEGs themselves, rather than because depression is polygenic.
So, among the genes that cause IR, are there any that are particularly likely to be common markers for depression? Depression is an immune disorder. Therefore, among the IR genes analysed in this study, the 34 genes identified as immune-related (Figure 3D) are likely to be good candidates. In addition, immune-related genes change with depression, and the IR genes most likely to interact with them are most likely to change with depression, so IR genes with a high ranking for interaction with immune-related genes, shown in Figure 3FJK, also have a high potential to be markers. Also, hub IR genes with many connections in the interactome (Figure 4B), which we discussed earlier, are also good candidates.
In terms of common markers for depression, a particular highlight of the present study is the detection of a number of cilia-related genes (32 genes; Figure 3C) as IR genes. This may reflect the functional stress state of cilia as antennae in leukaemic cells, although the presence of cilia on leukaemic cells is controversial (55). It is known that when dendritic cells present antigens to T cells, they form structures known as immunological synapses, in which the internal environment of the T cell resembles that of cilia (56, 57, 58). Therefore, the observation of IR in cilia genes may represent a failure of T cells to recognise antigens during depression. An interesting possibility is that cilia-related genes are not equally likely to be IR genes. Of the 1117 ciliary genes currently known, IR was observed in 32 genes in this study (Figure 3C). Surprisingly, of the 37 ciliary genes currently known to cause Joubert syndrome, six (AHI1 (59), CELSR2 (60), CEP104 (61), IFT172 (62), NPHP1 (63), TMEM107 (64)) were found to be among the IR genes. In addition, four of these six genes were found to be restored by Japanese herbal medicine. Thus, the Joubert syndrome genes are particularly enriched in IR and highly responsive to Japanese herbal medicine, making these genes probably the best candidates for marker genes for depression. AHI1 and NPHP1 were also found to be pathways for recovery, as described below (Figure 5 & 6). Future clinical trials are awaited to confirm these possibilities, where it will be necessary to determine more reads during sequencing, assuming rMATs is used (rMATs requires approximately five times more sequencing reads than DEG).
When these IR-recovered genes were mapped onto the IR-DEG interactome, 10 pathways were discovered that recovered in association with each other. Although each of these 10 pathways deserves detailed investigation (most of them were newly discovered in this study), it is important to emphasise that in each of the 10 pathways shown here, changes in the IR of one gene are linked to changes in the IR or DEG of another gene, forming a single functional unit (which we call a gear). We will discuss a few of these. The first is the NPHP1-AHI1 pathway (Figure 6G). As mentioned above, these two genes are involved in cilia function and their mutations cause a ciliopathy called Joubert syndrome (59, 65, 66, 67). It has been shown experimentally that jouberin, a protein encoded by AHI1, can interact with nephrocystin, a protein encoded by NPHP1, using the yeast two-hybrid system (68). The two proteins form a heterodimer, and mutations in AHI1 that do not form a heterodimer (i.e. V443D in AHI1) alter the intracellular localisation of AHI1 and NHPH1 so that the two proteins can, although not always, behave as if they were one protein (59). It is interesting to note that the introns of these two mRNAs are reduced in depression and both are restored by the administration of the herbal medicine (Figure 6G). In other words, the mRNAs transcribed from these two genes seem to be under the same control mechanism of RNA processing, as if they were the same mRNA. These observations remind us of a model we have recently proposed that there may be a novel mechanism that senses the correct level of functional proteins in the cytoplasm and transmits this information to the nucleus to regulate the level of IR (29). If such a mechanism exists, it would mean that introns in the genes for AHI1 and NPHP1 are regulated by a common factor.
In the case of the MYLK-MYH10 pathway (Figure 6I), inflammatory inputs activate MYLK and phosphorylate the L-chain of myosin (47). This causes the contracted L-chain of myosin to transmit information to the H-chain, which in turn regulates the copy number of mitochondrial DNA, which is tightly bound to the non-muscle H-chain (45). In this biological GEAR, the input is inflammation and the output is the control of the number of copies of mitochondrial DNA. The other eight pathways, including the two already postulated, need to be demonstrated biochemically in practice, but brief outlines of the hypothetical pathways are given in the legend of Figure 6.
Figure 6K shows the 10 pathways restored by HKT mapped on the IR-DEG interactome described in this study. This interactome was generated using data from depressed patients and controls only. This means that if a different drug with a different effect to the one used here was used, the new pathways restored by the drug could be detected. Accordingly, such an IR-DEG interactome should be useful for assessing the efficacy of all drugs, including herbal medicines, and for finding new pathways affected by drugs.
In short, we have shown in this paper that IR can be an excellent marker of depression. The combination of network analysis and drug response gene analysis may also reveal new pathways of drug efficacy. The strategy presented here are not limited to the analysis of depression, but can be applied to any disease.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Authors’ Contributions
Norihiro Okada conceived, supervised and validated the project and wrote and finalised the manuscript. Kenshiro Oshima analysed and visualised the data and wrote the Materials and Methods and legends. Akiko Maruko analysed the PCR data. Mariko Sekine suggested the application of the IR method to human subjects. Naoki Ito performed PBMC isolation. Akino Wakasugi analysed the human data. Eiko Mori and Hiroshi Odaguchi designed and performed the clinical research. Yoshinori Kobayashi organised the human COI project. All authors read, revised, edited, and approved the final manuscript.
Competing interests
N.O., K.O. and A.M. received a research grant from TSUMURA and CO. Although TSUMURA is a manufacturer of the Japanese herbal (Kampo) medicine, the company did not provide the Kampo used in this study, which was prepared at the Kitasato University Oriental Medicine Research Center. All research members of this study declare no potential conflicts of interest.
Footnotes
Change of the gene number from 127 to 129 IncIR and from 169 to 172 DecIR in the result section. Other minor changes for example incorporation of figure numbers.
Reference
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- 19.↵
- 20.↵
- 21.↵
- 22.↵
- 23.↵
- 24.↵
- 25.↵
- 26.↵
- 27.↵
- 28.↵
- 29.↵
- 30.↵
- 31.↵
- 32.↵
- 33.↵
- 34.↵
- 35.↵
- 36.↵
- 37.↵
- 38.↵
- 39.↵
- 40.↵
- 41.↵
- 42.↵
- 43.↵
- 44.↵
- 45.↵
- 46.↵
- 47.↵
- 48.↵
- 49.↵
- 50.↵
- 51.↵
- 52.↵
- 53.↵
- 54.↵
- 55.↵
- 56.↵
- 57.↵
- 58.↵
- 59.↵
- 60.↵
- 61.↵
- 62.↵
- 63.↵
- 64.↵
- 65.↵
- 66.↵
- 67.↵
- 68.↵
- 69.↵
- 70.↵
- 71.↵
- 72.↵
- 73.↵
- 74.↵
- 75.↵
- 76.↵
- 77.↵
- 78.↵
- 79.↵
- 80.↵
- 81.↵
- 82.↵
- 83.↵
- 84.↵
- 85.↵
- 86.↵
- 87.↵
- 88.↵
- 89.↵
- 90.↵
- 91.↵
- 92.↵
- 93.↵
- 94.↵
- 95.↵
- 96.↵
- 97.
- 98.
- 99.
- 100.
- 101.
- 102.
- 103.
- 104.
- 105.
- 106.
- 107.
- 108.
- 109.
- 110.
- 111.
- 112.
- 113.
- 114.
- 115.
- 116.
- 117.
- 118.
- 119.
- 120.
- 121.
- 122.
- 123.
- 124.
- 125.
- 126.
- 127.
- 128.
- 129.
- 130.
- 131.
- 132.
- 133.
- 134.
- 135.
- 136.
- 137.
- 138.
- 139.
- 140.
- 141.
- 142.
- 143.
- 144.
- 145.
- 146.
- 147.
- 148.
- 149.
- 150.
- 151.
- 152.
- 153.
- 154.
- 155.
- 156.